[1] |
CAI Haili, ZHANG Xiaomeng, LIU Yadi, CHEN Lijuan, WANG Yu, ZHANG Bing.
Preventive Strategies for Anthracycline-Induced Cardiotoxicity Using Traditional Chinese Medicine via Ferroptosis Regulation
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 876-882.
|
[2] |
ZHAO Jie, GAO Minge, CHANG Hong, FAN Huixia.
Pathogen Distribution, Drug Resistance and Drug Use in Neonates with Necrotizing Enterocolitis Complicated with Sepsis
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 909-913.
|
[3] |
SHI Qi, WANG Jianxin, WANG Guijie, LU Yueyang, ZHU Jiaxu, GAO Rui.
Adjuvant Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Qingqi Huatan Pills: a Systematic Review
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 914-919.
|
[4] |
YING Jie, XU Xiaolong, LI Bo, LIU Tengwen, LIU Qingquan.
Clinical Applications of Jinhua Qinggan Granules in the Treatment of Mild Influenza: a Meta-Analysis
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 920-923.
|
[5] |
LIANG Jie.
172 Cases of Adverse Drug Reactions Induced by Antineoplastic Drugs
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 928-932.
|
[6] |
CAO Kai, QIAN Peipei, GAO Xin, YANG Futian, ZHAO Liang, XU Bingxin, ZHANG Xianjun.
Mining of Risk Signals Adverse Events Related to Drug-Induced Salivary Gland Calculus Based on FAERS Database
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 799-804.
|
[7] |
LEI Jianlin, WANG Na, WANG Wenzheng, WANG Yan.
One Case of Phenytoin Intoxication Caused by Compound Phenytoin Sodium Ephedrine Hydrochloride and Theophylline Tablets
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 819-822.
|
[8] |
SHEN Lu, LIU Cuili, WANG Yi, HAO Mingqiang, WANG Yali, ZHU Huijuan, WU Chen, YANG Yang.
Precision Pharmacovigilance for Cell and Gene Therapy Products
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(6): 633-639.
|
[9] |
LIU Yiyu, LI Yanwen, WANG Jiao, ZHOU Wenjing, PENG Yumeng, HE Wenbin, LI Zhiyong.
Efficacy Semantic Mining and Safety Analysis of Chinese Patent Medicines for Headache
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(6): 674-679.
|
[10] |
XIE Ziyue, WANG Chengxiang, HU Yanpeng, LI Lei, CUI Herong.
Clinical Medications and Safety Analysis of Traditional Chinese Medicine for Post-Infection Cough
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 507-512.
|
[11] |
FAN Liping, LU Shu, SUN Huiyuan.
Efficacy and Safety of Panax Quinquefolium Saponin in Adjuvant Treatment of Angina Pectoris of Coronary Heart Disease: a Meta-Analysis
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 570-574.
|
[12] |
WANG Fengxin, LI Lei, HUANG Xurui, ZHAO Yun, LING Ruby, YANG Yang, LIANG Changhao, ZENG Yuntao, ZHENG Yingjun, TANG Yuanchen, LIU Jiatao, WANG Chengxiang, WEN Tiancai, LI Ping.
Efficacy and Safety of Danshen Decoction in Treatment of Coronary Heart Disease
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 575-579.
|
[13] |
CHEN Huan, LIANG Jun, ZHAO Wei, XIA Qingrong.
Clinical Features and Risk Factors of Liver Injury Induced by Atypical Antipsychotic Drugs
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(4): 410-414.
|
[14] |
YANG Jingqi, XU Baohai, ZHANG Jing, JIANG Yang, SHI Fang.
Pharmacovigilance for Traditional Chinese Patent Medicines for Orthopedics
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(4): 436-441.
|
[15] |
YANG Xuyun, SUN Yang, TIAN Chunhua, HU Zengyao.
A National Pharmacovigilance Management System in a New Era
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 276-281.
|